Phone diary study aims to uncover Stress-Brain link in breast cancer survivors

NCT ID NCT07054723

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study tests whether a 14-day mobile diary is a practical way to measure daily stress and thinking (cognitive) changes in breast cancer survivors. Researchers will enroll 30 racially diverse women aged 40 and older who are at least five years past diagnosis. Participants complete short morning and evening surveys on a provided phone. The goal is to see if this method is feasible and reliable, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Thomas Jefferson University

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mobile Daily Diary (behavioral intervention)

What this could lead to

If successful, this could provide a practical way to measure how daily stress affects thinking in breast cancer survivors, pointing toward future support strategies.

What could go wrong

This is a small, early feasibility study with only 30 participants. It is not designed to prove any treatment works, and results may not apply to all survivors.

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm cognitive disorder Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.